The microbiome-driven liquid biopsy company

Micronoma is the first cancer-detection company utilizing signals from some of the most ancient matter in the world, microbial nucleic acid, dedicated to empowering clinicians to diagnose cancer at an early stage with minimally invasive, microbiome-driven liquid biopsy technology. Micronoma was founded in 2019 by leaders in microbiome research with the goal of revolutionizing and advancing the practice of early cancer diagnostics and personalized treatment through sensitive microbiome techniques, so that patients’ needs can be identified and addressed by their clinicians at the earliest stage for a better chance to live longer, healthier lives. The company is headquartered in San Diego, Calif.